Study on XsunX's Solar Cell Technology Offers Positive Projections

XsunX, Inc. (OTC Bulletin Board: XSNX), the developer of advanced, thin-film photovoltaic (TFPV) solar cell technologies and manufacturing processes, announced today the favorable results from a study done by IBIS Associates, Inc., a technology strategy and business development consulting company specializing in advanced materials and manufacturing technologies, regarding the potential impact of XsunX's hybrid solar technology, CIGSolar™, on the global solar photovoltaic (PV) market in terms of efficiency and savings.

The study projects that portions of the Global PV market utilizing multi-crystalline silicon solar cells could achieve savings of over $646 million by replacing only 500 megawatts of multi-crystalline silicon usage with new XsunX CIGS based solar cells by 2015. The study's five year projection utilized XsunX's Joint Venture licensing model under which it plans to deploy manufacturing capacity of CIGSolar™ which is currently under development by XsunX. This savings was determined by utilizing the National Renewable Energy Laboratories (NREL's) Solar Advisor Model which forecasts the savings from the projected efficiency gains of CIGSolar™ technology as a replacement for the use of multi-crystalline silicon cells.

"With the industry's renewed focus on CIGS untapped potential, we believe we are positioned to reach the market at an optimal time," said Tom Djokovich, CEO, XsunX, Inc. "It became very clear to us at the InterSolar conference in San Francisco this month that CIGS was becoming the "darling" of the solar industry, and XsunX is working to capitalize on this timing."

The Company's development objectives for CIGSolar™, which were launched last fall, include leveraging and adapting expertise and cross-cutting technologies from the hard disk media and high-speed flex circuit printing industries with thin-film CIGS techniques in the mass production of individual CIGS solar cells. This idea to reach outside of the solar industry to adapt useful technologies from other industries has begun to take a broader hold as evidenced by a recent U.S. Department of Energy (DOE) research grant that tasked the renewable energy industry "to identify and accelerate the development of cross-cutting and unique products or processes that are expected to have a disruptive impact on the photovoltaics (PV) industry."

Of all the PV materials, CIGS exhibits the largest performance "gap" between CIGS laboratory efficiencies and average commercial module efficiencies, a gap of approximately 50% below laboratory efficiency. Many experts believe the reason for the difference between laboratory and commercial efficiencies is normal compositional variation associated with scaling from laboratory processes that focus on smaller areas to large area commercial production. XsunX's new approach aims to eliminate the variations while maintaining commercial production volumes.

IBIS also reported that "XsunX's PV Cell technology in many ways can be thought of as a "drop-in" replacement for the current multi-crystalline silicon cell value stream, with the notable exception that it is much more capital efficient and cost effective. Moreover, XsunX's CIGS PV cells have the potential to eventually "outstrip" the baseline mc-Si cell in terms of conversion efficiency."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.